Black Rock Inc. Relay Therapeutics, Inc. Call Options Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding RLAY
# of Institutions
202Shares Held
156MCall Options Held
207KPut Options Held
40K-
Sb Investment Advisers (Uk) LTD London, X027.9MShares$156 Million1.63% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.5MShares$81 Million0.0% of portfolio
-
Casdin Capital, LLC New York, NY9.25MShares$51.8 Million5.09% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.38MShares$41.3 Million0.88% of portfolio
-
Jpmorgan Chase & CO New York, NY5.52MShares$30.9 Million0.0% of portfolio
About Relay Therapeutics, Inc.
- Ticker RLAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 120,219,000
- Market Cap $673M
- Description
- Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...